Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

LAM 003

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

OrphAI Therap

Drug class:

HSP90 inhibitor

Related drugs:

FLT3 D835	Acute Myelogenous Leukemia	FLT3 D835	Acute Myelogenous Leukemia	LAM 003 Sensitive: D – Preclinical LAM 003 Sensitive : D	LAM 003 Sensitive: D – Preclinical LAM 003 Sensitive : D
FLT3-ITD mutation	Acute Myelogenous Leukemia	FLT3-ITD mutation	Acute Myelogenous Leukemia	LAM 003 Sensitive: D – Preclinical LAM 003 Sensitive : D	LAM 003 Sensitive: D – Preclinical LAM 003 Sensitive : D
FLT3-ITD mutation	Acute Myelogenous Leukemia	FLT3-ITD mutation	Acute Myelogenous Leukemia	venetoclax + LAM 003 Sensitive: D – Preclinical venetoclax + LAM 003 Sensitive : D	venetoclax + LAM 003 Sensitive: D – Preclinical venetoclax + LAM 003 Sensitive : D